Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05444283 · ClinicalTrials.gov registry record
Genomic Predictors of Recurrent Pregnancy Loss
A clinical trial of Recurrent Pregnancy Loss, sponsored by Yale University.
- Recruiting
- Registry status
- 500
- Enrollment target
- 10
- Study locations
NCT05444283 is a study of Recurrent Pregnancy Loss that is actively recruiting participants, run by Yale University. The registered enrollment target is 500 participants. The trial reports 10 study locations across 8 states.
The verdict
NCT05444283, a study of Recurrent Pregnancy Loss, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 10
- Study locations
Study Summary
The overall goals of this proposal are to determine the genetic architecture of recurrent pregnancy loss (RPL) and to discover genomic predictors of RPL.
Conditions Studied
Study Locations (10)
Illinois
- Northwestern University - Chicago
- University of Chicago - Chicago
Texas
- University of Texas at Austin - Austin
- University of Texas at San Antonio - San Antonio
Colorado
- University of Colorado - Aurora
Connecticut
- Yale University - New Haven
Maryland
- Gaelle Massoud - Baltimore
Michigan
- Wayne State University - Detroit
New York
- Columbia University - New York
Pennsylvania
- Pennsylvania State University - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05444283
The ClinicalTrials.gov registry entry for NCT05444283 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Recurrent Pregnancy Loss appearing as the primary indexed condition, and to 0 interventions.
NCT05444283 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Illinois, Texas, Colorado.
Frequently Asked Questions
What is clinical trial NCT05444283 about?
NCT05444283 is a clinical study titled "Genomic Predictors of Recurrent Pregnancy Loss". The overall goals of this proposal are to determine the genetic architecture of recurrent pregnancy loss (RPL) and to discover genomic predictors of RPL.
What is the current status of trial NCT05444283?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2021-09-01. Estimated completion is 2026-12.
What conditions does trial NCT05444283 study?
This clinical trial studies the following conditions: Recurrent Pregnancy Loss.
Who is sponsoring clinical trial NCT05444283?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05444283 being conducted?
This trial has 10 study locations across Colorado, Connecticut, Illinois, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Recurrent Pregnancy Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.